Bacteria-derived chimeric toxins as potential anticancer agents
Cancer is one of the major causes of death globally, requiring everlasting efforts to develop novel, specific, effective, and safe treatment strategies. Despite advances in recent years, chemotherapy, as the primary treatment for cancer, still faces limitations such as the lack of specificity, drug...
Main Authors: | Saeed Khoshnood, Hadis Fathizadeh, Foroogh Neamati, Babak Negahdari, Piyush Baindara, Mohd Azmuddin Abdullah, Mohammad Hossein Haddadi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.953678/full |
Similar Items
-
Bacterial Toxins for Cancer Therapy
by: Nour-Imene Zahaf, et al.
Published: (2017-07-01) -
Targeted Toxins in Brain Tumor Therapy
by: Walter A. Hall, et al.
Published: (2010-11-01) -
PLASMID DESIGN FOR PRODUCTION OF CHIMERIC ANTIBODIES WITH DEFINED SPECIFICITY IN EUKARYOTES
by: A. S. Oksanich, et al.
Published: (2017-12-01) -
In-vivo Evaluation of DT386-BR2, A Promising Anticancer Fusion Protein, in Mice Model
by: Fatemeh Shafiee, et al.
Published: (2017-07-01) -
Targeted Diphtheria Toxin-Based Therapy: A Review Article
by: Fatemeh Shafiee, et al.
Published: (2019-10-01)